Literature DB >> 23583466

Management of gastric polyps: an endoscopy-based approach.

Yasser H Shaib1, Massimo Rugge, David Y Graham, Robert M Genta.   

Abstract

The endoscopic finding of a gastric polyp and the histopathologic report that follows may leave clinicians with questions that have not been addressed in formal guidelines: do all polyps need to be excised, or can they just be sampled for biopsy? If so, which ones and how many should be sampled? What follow-up evaluation is needed, if any? This review relies on the existing literature and our collective experience to provide practical answers to these questions. Fundic gland polyps, now the most frequent gastric polyps in Western countries because of widespread use of proton pump inhibitors, and hyperplastic polyps, the second most common polyps notable for their association with gastritis and their low but important potential for harboring dysplastic or neoplastic foci, are discussed in greater detail. Adenomas have had their name changed to raised intraepithelial neoplasia and are decreasing in parallel with Helicobacter pylori infection; however, they do retain their importance as harbingers of gastric cancer, particularly in East Asia. Gastrointestinal stromal tumors have low incidence and no known associations, but their malignant potential is high; early diagnosis and proper management are crucial. Although rare and benign, inflammatory fibroid polyps need to recognized, particularly by pathologists, to avoid misdiagnosis. Gastric neuroendocrine tumors (carcinoids) are important because of their association with either atrophic gastritis or the multiple endocrine neoplasia syndromes; those that do not arise in these backgrounds have high malignant potential and require aggressive management. The review concludes with some practical suggestions on how to approach gastric polyps detected at endoscopy.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ECL; EGD; Endoscopic Management; GIST; Gastric Polyps; OLGA; Operative Link for Gastritis Assessment; PPI; enterochromaffin-like; esophagogastroduodenoscopy; gastrointestinal stromal tumors; proton pump inhibitor

Mesh:

Year:  2013        PMID: 23583466      PMCID: PMC3962745          DOI: 10.1016/j.cgh.2013.03.019

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  81 in total

1.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Nanoneoadjuvant therapy of gastrointestinal stromal tumor (GIST).

Authors:  Ronald P DeMatteo
Journal:  Ann Surg Oncol       Date:  2009-01-24       Impact factor: 5.344

3.  Endoscopic features of gastric inflammatory fibroid polyps.

Authors:  M Matsushita; K Hajiro; K Okazaki; H Takakuwa
Journal:  Am J Gastroenterol       Date:  1996-08       Impact factor: 10.864

4.  The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis.

Authors:  Lisette G Capelle; Annemarie C de Vries; Jelle Haringsma; Frank Ter Borg; Richard A de Vries; Marco J Bruno; Herman van Dekken; Jos Meijer; Nicole C T van Grieken; Ernst J Kuipers
Journal:  Gastrointest Endosc       Date:  2010-04-09       Impact factor: 9.427

Review 5.  Review article: the long-term use of proton-pump inhibitors.

Authors:  A S Raghunath; C O'Morain; R C McLoughlin
Journal:  Aliment Pharmacol Ther       Date:  2005-08       Impact factor: 8.171

6.  Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients.

Authors:  P Domizio; I C Talbot; A D Spigelman; C B Williams; R K Phillips
Journal:  J Clin Pathol       Date:  1990-09       Impact factor: 3.411

Review 7.  Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors:  M Miettinen; J Lasota
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

8.  Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A.

Authors:  R Fossmark; Ø Sørdal; C S Jianu; G Qvigstad; I S Nordrum; M Boyce; H L Waldum
Journal:  Aliment Pharmacol Ther       Date:  2012-10-16       Impact factor: 8.171

Review 9.  Management of gastric polyps: a pathology-based guide for gastroenterologists.

Authors:  Susanne W Carmack; Robert M Genta; David Y Graham; Gregory Y Lauwers
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-06       Impact factor: 46.802

10.  Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes.

Authors:  Susan C Abraham; Seun Ja Park; Jae-Hyuk Lee; Lilian Mugartegui; Tsung-Teh Wu
Journal:  Mod Pathol       Date:  2003-08       Impact factor: 7.842

View more
  31 in total

Review 1.  Vanek's tumor of the small bowel in adults.

Authors:  Bassam Abboud
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

2.  Evaluation of clinico-pathological features and Helicobacter pylori infection in gastric inflammatory fibroid polyps.

Authors:  Andreia Albuquerque; Elisabete Rios; Fátima Carneiro; Guilherme Macedo
Journal:  Virchows Arch       Date:  2014-09-26       Impact factor: 4.064

3.  Hyperplastic gastric polyposis complicated by a high-grade sarcomatoid malignancy.

Authors:  Hugh J Freeman; Peter W C Kwan; James R Gray; Douglas Webber
Journal:  Can J Gastroenterol Hepatol       Date:  2014-05

Review 4.  Laparoscopic fundoplication for gastroesophageal reflux disease.

Authors:  Marzio Frazzoni; Micaela Piccoli; Rita Conigliaro; Leonardo Frazzoni; Gianluigi Melotti
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

5.  Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.

Authors:  Hajime Anjiki; Ken-Ichi Mukaisho; Yu Kadomoto; Hisakazu Doi; Kunio Yoshikawa; Takahisa Nakayama; Diem Thi-Ngoc Vo; Takanori Hattori; Hiroyuki Sugihara
Journal:  Clin J Gastroenterol       Date:  2017-02-03

Review 6.  Autoimmune atrophic gastritis--pathogenesis, pathology and management.

Authors:  William L Neumann; Elizabeth Coss; Massimo Rugge; Robert M Genta
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-06-18       Impact factor: 46.802

7.  Changes in the spectrum of gastric polyps in the Chinese population.

Authors:  Nan-Nan Fan; Jing Yang; Gang Sun; Zhong-Sheng Lu; En-Qiang Ling Hu; Xiang-Dong Wang; Yun-Sheng Yang
Journal:  World J Gastroenterol       Date:  2015-09-07       Impact factor: 5.742

8.  Helicobacter pylori Eradication Regressed Gastric Hyperplastic Polyp: A Randomized Controlled Trial.

Authors:  Su Youn Nam; Sang Won Lee; Seong Woo Jeon; Yong Hwan Kwon; Hyun Seok Lee
Journal:  Dig Dis Sci       Date:  2020-01-23       Impact factor: 3.199

Review 9.  Rare Neoplasia of the Stomach.

Authors:  Christia Schulz; Kersti Schütte; Pete Malfertheiner
Journal:  Gastrointest Tumors       Date:  2015-08-07

Review 10.  Current Management of Benign Epithelial Gastric Polyps.

Authors:  Antonio R Cheesman; David A Greenwald; Shailja C Shah
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.